Breakthrough for Pulmonary Hypertension: Sotatercept Gets MHRA Nod In a groundbreaking development, the Medicines and Healthcare products Regulatory Agency (MHRA) has approved Sotatercept, marketed under the name Winrevair, for treating pulmonary arterial hypertensio...

www.linkedin.com/pulse/breakt...

Breakthrough for Pulmonary Hypertension: Sotatercept Gets MHRA Nod

kstrategyand.com/pharma-news

#Winrevair #Sotatercept #PAHTreatment #PulmonaryHypertension #MedicalBreakthrough #MHRAApproval #SelfInjectionTherapy #Humanteconomy #Humantec #KStrategyand